May. 16, 2023
Recently, the team of Professor Qi Hongbo of the Women and Children’s Hospital of CQMU, who is also the director of the Laboratory of Maternal and Fetal Medicine of the First Affiliated Hospital......
View more!May. 04, 2023
Recently, Professor Li Xi and associate research Professor Wang Shujin of the “Research Platform for Obesity and Related Metabolic Diseases” of the Institute of Life Sciences of CQMU, together ......
View more!May. 04, 2023
On December 29th, 2022, the Institute of Scientific and Technical Information of China has released the “Statistical Data of Chinese Scientific and Technical Reports in 2022” ( Hereinafter referr......
View more!May. 04, 2023
Recently, under the joint guidance of Associate Professor Zang Guangchao from the Experimental Teaching Management Centre, and Associate Professor Zhang Yuchan from the Graduate School, a team of u......
View more!May. 04, 2023
Metabolic Associated Fatty Liver Disease (MAFLD) is a metabolic disorder which is affected by multiple factors, such as genetic and environmental influences. It can lead to elevated risks of cirrho......
View more!Nov. 09, 2022
Recently, Professor GUO Shuliang’s team from the Department of Pulmonary and Critical Care Medicine (PCCM) of the First Affiliated Hospital of CQMU published a treatise entitled "Combination Thera......
View more!Nov. 09, 2022
Professor LI Qifu’s team from the Endocrinology Department of the First Affiliated Hospital of CQMU published a paper titled "Prevalence and Characteristics of Adrenal Tumors in an Unselected Scre......
View more!Jun. 30, 2022
On April 8, Professor JIN Aishun from the College of Basic Medicine of CQMU and Kishi Hiroyuki, Atsushi Muraguchi, Kobayashi Eiji, and others from Department of Immunology of University of Toyama, ......
View more!Jun. 30, 2022
YANG Jian, director of the Department of Clinical Nutrition of the Third Affiliated Hospital of CQMU, published a review in a famous international journal Pharmacology & Therapeutics as the first a......
View more!Jun. 30, 2022
Professor YIN Yuehui’s team from the Cardiology Group of the Clinical Testing Facility of the Second Affiliated Hospital of CQMU assisted "Hybutimibe Tablets", produced by Zhejiang Hisun Pharmaceu......
View more!